PineBridge Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Buy
224,642
+24,365
+12% +$13.2M 0.93% 20
2025
Q4
$116M Buy
200,277
+62,601
+45% +$35.4M 0.86% 23
2025
Q3
$66.8M Buy
137,676
+4,223
+3% +$1.97M 0.5% 37
2025
Q2
$54.1M Sell
133,453
-27,767
-17% -$11.6M 0.43% 42
2025
Q1
$80.2M Buy
161,220
+35,405
+28% +$19.2M 0.64% 28
2024
Q4
$65.5M Buy
125,815
+26,466
+27% +$14.6M 0.49% 36
2024
Q3
$61.5M Sell
99,349
-3,027
-3% -$1.79M 0.46% 46
2024
Q2
$56.6M Sell
102,376
-9,395
-8% -$5.38M 0.46% 41
2024
Q1
$64.9M Buy
111,771
+21,773
+24% +$12.2M 0.52% 34
2023
Q4
$47.8M Buy
89,998
+6,140
+7% +$2.97M 0.44% 47
2023
Q3
$42.4M Sell
83,858
-38,878
-32% -$20.7M 0.47% 45
2023
Q2
$64M Sell
122,736
-16,114
-12% -$8.7M 0.69% 21
2023
Q1
$80M Buy
138,850
+50,548
+57% +$28.5M 0.9% 18
2022
Q4
$48.6M Sell
88,302
-217
-0.2% -$115K 0.59% 36
2022
Q3
$44.9M Sell
88,519
-31,164
-26% -$17.4M 0.58% 34
2022
Q2
$65M Sell
119,683
-9,704
-7% -$5.34M 0.82% 22
2022
Q1
$76.4M Buy
129,387
+40,865
+46% +$23.5M 0.82% 20
2021
Q4
$59.1M Buy
88,522
+4,465
+5% +$2.79M 0.6% 30
2021
Q3
$48M Sell
84,057
-4,709
-5% -$2.58M 0.57% 33
2021
Q2
$44.8M Buy
88,766
+5,043
+6% +$2.38M 0.52% 34
2021
Q1
$38.2M Buy
83,723
+33,615
+67% +$16M 0.49% 41
2020
Q4
$23.3M Buy
50,108
+33,720
+206% +$15.8M 0.36% 64
2020
Q3
$7.24M Buy
16,388
+13,384
+446% +$5.53M 0.12% 188
2020
Q2
$1.09M Sell
3,004
-20,668
-87% -$6.93M 0.02% 424
2020
Q1
$6.71M Buy
23,672
+22,720
+2,387% +$7.16M 0.16% 160
2019
Q4
$309K Sell
952
-14,491
-94% -$4.39M ﹤0.01% 860
2019
Q3
$4.5M Buy
15,443
+8,918
+137% +$2.55M 0.07% 267
2019
Q2
$1.92M Buy
6,525
+5,695
+686% +$1.57M 0.03% 376
2019
Q1
$227K Buy
830
+662
+394% +$165K ﹤0.01% 831
2018
Q4
$38K Buy
+168
New +$39.4K ﹤0.01% 994
2017
Q2
Sell
-32,693
Closed -$5.02M 1183
2017
Q1
$5.02M Buy
32,693
+4,026
+14% +$615K 0.13% 160
2016
Q4
$4.04M Buy
28,667
+218
+0.8% +$32.1K 0.12% 169
2016
Q3
$4.53M Buy
28,449
+450
+2% +$69.3K 0.2% 142
2016
Q2
$4.14M Sell
27,999
-11,949
-30% -$1.76M 0.21% 131
2016
Q1
$5.66M Buy
39,948
+1,495
+4% +$200K 0.29% 101
2015
Q4
$5.46M Sell
38,453
-8,688
-18% -$1.16M 0.23% 119
2015
Q3
$5.76M Sell
47,141
-1,350
-3% -$176K 0.25% 114
2015
Q2
$6.29M Buy
+48,491
New +$6.32M 0.25% 111
2014
Q2
Sell
-391
Closed -$47K 1107
2014
Q1
$47K Buy
391
+24
+7% +$2.85K ﹤0.01% 1022
2013
Q4
$41K Sell
367
-12
-3% -$1.19K ﹤0.01% 1035
2013
Q3
$35K Hold
379
﹤0.01% 987
2013
Q2
$32K Buy
+379
New +$31.5K ﹤0.01% 1006

Other funds holding TMO

PineBridge Investments's TMO Position: Q1 2026 in Review

PineBridge Investments increased its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, buying an estimated $13.2M and bringing the position to 224,642 shares worth $110M. The position accounts for 0.93% of the portfolio, ranked #20.

PineBridge Investments first reported a position in TMO in Q2 2013 and has held it in 42 quarters since. The position peaked at $116M in Q4 2025. 2,595 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • PineBridge Investments held 224,642 shares of Thermo Fisher Scientific worth $110M as of Q1 2026.
  • PineBridge Investments bought 24,365 Thermo Fisher Scientific shares in Q1 2026, an estimated $13.2M.
  • Thermo Fisher Scientific made up 0.93% of PineBridge Investments's portfolio in Q1 2026, its #20 holding.
  • PineBridge Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 42 quarters since.
  • PineBridge Investments's Thermo Fisher Scientific position peaked at $116M in Q4 2025.
  • 2,595 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.